137 related articles for article (PubMed ID: 8346559)
1. Secondary leukemia following treatment for Hodgkin's disease.
Salvagno L; Simonato L; Sorarù M; Bianco A; Chiarion-Sileni V; Aversa SM; Camporese R; Garofolin P; Fiorentino M
Tumori; 1993 Apr; 79(2):103-7. PubMed ID: 8346559
[TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
3. Leukemia following Hodgkin's disease.
Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
[TBL] [Abstract][Full Text] [Related]
4. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
Cadman EC; Capizzi RL; Bertino JR
Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
[TBL] [Abstract][Full Text] [Related]
5. Fifteen-year experience in Hodgkin's disease: role of combined modality treatment and splenectomy in the incidence of secondary acute leukemia.
Zinzani PL; Fiacchini M; Mazza P; Gherlinzoni F; Bocchia M; Tura S
Haematologica; 1991; 76(4):305-10. PubMed ID: 1724437
[TBL] [Abstract][Full Text] [Related]
6. Incidence of second cancers in patients treated for Hodgkin's disease.
Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
[TBL] [Abstract][Full Text] [Related]
7. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.
van Leeuwen FE; Somers R; Taal BG; van Heerde P; Coster B; Dozeman T; Huisman SJ; Hart AA
J Clin Oncol; 1989 Aug; 7(8):1046-58. PubMed ID: 2754447
[TBL] [Abstract][Full Text] [Related]
9. Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.
Devereux S; Selassie TG; Vaughan Hudson G; Vaughan Hudson B; Linch DC
BMJ; 1990 Nov; 301(6760):1077-80. PubMed ID: 2249071
[TBL] [Abstract][Full Text] [Related]
10. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
Blayney DW; Longo DL; Young RC; Greene MH; Hubbard SM; Postal MG; Duffey PL; DeVita VT
N Engl J Med; 1987 Mar; 316(12):710-4. PubMed ID: 3821809
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature.
Rosner F; Grünwald H
Am J Med; 1975 Mar; 58(3):339-53. PubMed ID: 1090158
[TBL] [Abstract][Full Text] [Related]
12. Acute leukemia after the treatment of Hodgkin's disease.
Henry-Amar M; Dietrich PY
Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
[TBL] [Abstract][Full Text] [Related]
13. Concomitant illness in patients treated for Hodgkin's disease.
Bookman MA; Longo DL
Cancer Treat Rev; 1986 Jun; 13(2):77-111. PubMed ID: 3527412
[No Abstract] [Full Text] [Related]
14. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
[TBL] [Abstract][Full Text] [Related]
15. Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
J Clin Oncol; 1986 Jun; 4(6):830-7. PubMed ID: 3711960
[TBL] [Abstract][Full Text] [Related]
16. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Tester WJ; Kinsella TJ; Waller B; Makuch RW; Kelley PA; Glatstein E; DeVita VT
J Clin Oncol; 1984 Jul; 2(7):762-9. PubMed ID: 6547479
[TBL] [Abstract][Full Text] [Related]
17. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
[TBL] [Abstract][Full Text] [Related]
18. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
Swerdlow AJ; Douglas AJ; Hudson GV; Hudson BV; Bennett MH; MacLennan KA
BMJ; 1992 May; 304(6835):1137-43. PubMed ID: 1392790
[TBL] [Abstract][Full Text] [Related]
19. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia following treatment of Hodgkin's disease: a review.
Grünwald HW; Rosner F
Cancer; 1982 Aug; 50(4):676-83. PubMed ID: 6953991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
